These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Phosphate Binders and Targets Over Decades: Do We have it Right Now? Marcuccilli M; Chonchol M; Jovanovich A Semin Dial; 2017 Mar; 30(2):134-141. PubMed ID: 28064444 [TBL] [Abstract][Full Text] [Related]
24. Use of phosphate-binding agents is associated with a lower risk of mortality. Cannata-Andía JB; Fernández-Martín JL; Locatelli F; London G; Gorriz JL; Floege J; Ketteler M; Ferreira A; Covic A; Rutkowski B; Memmos D; Bos WJ; Teplan V; Nagy J; Tielemans C; Verbeelen D; Goldsmith D; Kramar R; Martin PY; Wüthrich RP; Pavlovic D; Benedik M; Sánchez JE; Martínez-Camblor P; Naves-Díaz M; Carrero JJ; Zoccali C Kidney Int; 2013 Nov; 84(5):998-1008. PubMed ID: 23823605 [TBL] [Abstract][Full Text] [Related]
25. Phosphorus binders: The new and the old, and how to choose. Sekar A; Kaur T; Nally JV; Rincon-Choles H; Jolly S; Nakhoul GN Cleve Clin J Med; 2018 Aug; 85(8):629-638. PubMed ID: 30102593 [TBL] [Abstract][Full Text] [Related]
26. An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovations. Cozzolino M; Ketteler M; Wagner CA Expert Opin Ther Targets; 2020 May; 24(5):477-488. PubMed ID: 32191548 [No Abstract] [Full Text] [Related]
27. Treatment options for hyperphosphatemia in feline CKD: what's out there? Kidder AC; Chew D J Feline Med Surg; 2009 Nov; 11(11):913-24. PubMed ID: 19857854 [TBL] [Abstract][Full Text] [Related]
28. The challenge of controlling phosphorus in chronic kidney disease. Cannata-Andía JB; Martin KJ Nephrol Dial Transplant; 2016 Apr; 31(4):541-7. PubMed ID: 25770169 [TBL] [Abstract][Full Text] [Related]
29. [Phosphorus: a new cardiovascular risk factor?]. Insalaco M; Scuderi R; Zanoli L; Galeano D; Failla A; Fatuzzo P; Granata A Clin Ter; 2015; 166(6):e389-400. PubMed ID: 26794822 [TBL] [Abstract][Full Text] [Related]
30. Contemporary management of phosphorus retention in chronic kidney disease: a review. Amiri FS Clin Exp Nephrol; 2015 Dec; 19(6):985-99. PubMed ID: 26032778 [TBL] [Abstract][Full Text] [Related]
32. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study. Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389 [TBL] [Abstract][Full Text] [Related]
33. Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk. Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ Nephrology (Carlton); 2012 Jul; 17(5):433-44. PubMed ID: 22574672 [TBL] [Abstract][Full Text] [Related]
34. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state. Six I; Maizel J; Barreto FC; Rangrez AY; Dupont S; Slama M; Tribouilloy C; Choukroun G; Mazière JC; Bode-Boeger S; Kielstein JT; Drüeke TB; Massy ZA Cardiovasc Res; 2012 Oct; 96(1):130-9. PubMed ID: 22822101 [TBL] [Abstract][Full Text] [Related]
35. Dietary calcium intake does not meet the nutritional requirements of children with chronic kidney disease and on dialysis. McAlister L; Silva S; Shaw V; Shroff R Pediatr Nephrol; 2020 Oct; 35(10):1915-1923. PubMed ID: 32385527 [TBL] [Abstract][Full Text] [Related]
36. Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes. Bhandari SK; Liu IA; Kujubu DA; Huynh T; Behayaa H; Kovesdy CP; Kalantar-Zadeh K; Jacobsen SJ; Sim JJ Am J Nephrol; 2017; 45(5):431-441. PubMed ID: 28445887 [TBL] [Abstract][Full Text] [Related]
37. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Jamal SA; Vandermeer B; Raggi P; Mendelssohn DC; Chatterley T; Dorgan M; Lok CE; Fitchett D; Tsuyuki RT Lancet; 2013 Oct; 382(9900):1268-77. PubMed ID: 23870817 [TBL] [Abstract][Full Text] [Related]
38. The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease. Marks J; Debnam ES; Unwin RJ Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):481-7. PubMed ID: 23666413 [TBL] [Abstract][Full Text] [Related]
39. Design and baseline characteristics of the LANDMARK study. Ogata H; Fukagawa M; Hirakata H; Kaneda H; Kagimura T; Akizawa T; Clin Exp Nephrol; 2017 Jun; 21(3):531-537. PubMed ID: 27405619 [TBL] [Abstract][Full Text] [Related]